New Approaches to Treating B-Cell Cancers Induced by Epstein–Barr Virus

Abstract

Two preclinical studies show that boosting numbers of T cells or rendering T cells resistant to the immunosuppressant tacrolimus are potential approaches for the treatment of post-transplantation lymphoproliferative disease associated with EBV infection.